Table 1.

Characteristics of cases included in this study

Case #M/FAgeCAPS #Risk groupStudy groupLesion# of lesionsLargest lesion (mm)EUSDiagnosis
#104F84CAPS4ControlDisease controlNormal pancreasnanaNormal pancreasSuspicion of dilated CBD
#108M46CAPS5ControlDisease controlNormal pancreasnanaNormal pancreasSuspicion of a pancreatic lesion by CT
#109F54CAPS5ControlDisease controlNormal pancreasnanaNormal pancreasAbdominal pain
#122M59CAPS4ControlDisease controlNormal pancreasnanaNormal pancreasWeight loss
#123F47CAPS4ControlDisease controlNormal pancreasnanaNormal pancreasDuodenal diverticulum, history of acute pancreatitis
#131F56CAPS4ControlDisease controlNormal pancreasnanaNormal pancreasA lesion adjacent to celiac artery by CT
#134M76CAPS4ControlDisease controlNormal pancreasnanaNormal pancreasSuspicion of a pancreatic lesion by CT
#135F69CAPS4ControlDisease controlNormal pancreasnanaNormal pancreasSuspicion of a cystic lesion by EUS 3 years ago
#137F38CAPS4ControlDisease controlNormal pancreasnanaNormal pancreasCBD stone
#089F74CAPS5FamilialSurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#091F79CAPS5FamilialSurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#093M71CAPS5FamilialSurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#095M78CAPS4FamilialSurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#099M72CAPS4High risk—BRCA2SurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#121M67CAPS4High risk—BRCA2SurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#124F70CAPS5FamilialSurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#105M70CAPS4FamilialSurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#127M70CAPS5FamilialSurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#128M73CAPS4High risk—BRCA1SurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#129F70CAPS4FamilialSurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#130F69CAPS5FamilialSurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#132F67CAPS5FamilialSurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#133F65CAPS5FamilialSurveillanceNo mass, no cystnanaNormal pancreasCAPS surveillance
#090M77CAPS5High risk—p16SurveillanceCyst17Cyst in tailIPMN suspected by EUS
#092M74CAPS5FamilialSurveillanceCysts418Cysts in body and headIPMN suspected by EUS
#096M71CAPS4FamilialSurveillanceCysts25Cysts in body and tailIPMN suspected by EUS
#100M72CAPS4FamilialSurveillanceCysts37Cysts in bodyIPMN suspected by EUS
#110M75CAPS5FamilialSurveillanceCysts614Cysts in head, body and tailIPMN suspected by EUS
#111M70CAPS5FamilialSurveillanceCysts215Cysts in body and headIPMN suspected by EUS
#112M72CAPS4FamilialSurveillanceCysts211Cysts in head and bodyIPMN suspected by EUS
#113F58CAPS4FamilialSurveillanceCysts311Cysts in bodyIPMN suspected by EUS
#114M63CAPS4FamilialSurveillanceCysts316Cysts in tail, head and bodyIPMN suspected by EUS
#115M62CAPS5High risk—PJSSurveillanceCysts317Cysts in head, body and tailIPMN suspected by EUS
#116F38CAPS5High risk—PJSSurveillanceCysts417Cysts in head, tail and bodyIPMN suspected by EUS
#117F69CAPS5FamilialSurveillanceCysts511Cysts in head, tail, body, 5 mm hypoechoic lesion in tailIPMN suspected by EUS, follow-up a hypoechoic lesion
#118F53CAPS5High risk—BRCA2SurveillanceCyst112Cyst in bodyIPMN suspected by EUS
#119F68CAPS5FamilialSurveillanceCysts715Cysts in head and tailIPMN suspected by EUS
#120F54CAPS5FamilialSurveillanceCyst112Cyst in tailIPMN suspected by EUS
#126F72CAPS5FamilialSurveillanceCyst—5 mmCyst in uncinateCAPS surveillance
#136F57CAPS5High risk—PALB2SurveillanceCysts1312Cysts in head, tail and bodyIPMN suspected by EUS
#077M57CAPS5IncidentalPrecursor—LGMass134Normal pancreas, no evidence of massPathology: chronic pancreatitis, PanIN-2
#072F58CAPS4High risk—PRSS1Precursor—LGCyst112Cyst in body, chronic pancreatitis, 6-mm dilated MPDPathology: IPMN IGD, chronic pancreatitis, PanIN-2
#075M64CAPS4High risk—BRCA2Precursor—LGSolid lesion114Hypoechoic lesion in tailPathology: Chronic pancreatitis, PanIN-2
#076M69CAPS5FamilialPrecursor—LGCysts66Cysts in body and tail, 7-mm dilated MPDPathology: IPMN IGD, PanIN-1B
#107F61CAPS5IncidentalPrecursor—LGMPD dilatation110Dilated MPD, 10 mmPathology: IPMN IGD, PanIN-2
#087M65CAPS5IncidentalPrecursor—LGCyst134Cyst in body, 5-mm dilated MPDPathology: IPMN LGD
#071M65CAPS4FamilialPrecursor—LGCystsMany28Cysts in body, head and tailPathology: IPMN IGD, PanIN-2
#070aM62CAPS4FamilialPrecursor—ERCPCysts25Cysts in head and body, 6-mm dilated MPDPathology: incipient IPMN, PanIN-2
#079M57CAPS5McCune–Albright syndromePrecursor—McCune–Albright syndromeCystsMany17Cysts in head, body and tail, 13-mm dilated MPDMcCune-Albright syndrome, Pathology: IPMN LGD
#073F66CAPS4FamilialPrecursor—HGCysts1217Cysts in body, head and tailPathology: multifocal PanIN with focal HGD (PanIN-3)
#074F65CAPS4High risk—PJSPrecursor—HGCysts410Cysts in head and bodyPathology: IPMN HGD, PanIN-2
#081F87CAPS5IncidentalPrecursor—HGCyst128Cyst with solid component in headPathology: IPMN HGD
#098M77CAPS4IncidentalPrecursor—HGCysts221Cysts in head and bodyPathology: IPMN HGD, PanIN-2
#078F75CAPS5PCPCMass140Mass in head, 10-mm dilated MPDPathology: PDAC, stage IV, diagnosed by FNA
#080F78CAPS5PCPCMass136Mass in headPathology: PDAC, ypStage IB
#082M62CAPS5PCPCMass132Mass in head, 4-mm dilated MPDPathology: PDAC, stage IV, diagnosed by FNA
#083F72CAPS5PCPCMass137Mass in head, 6-mm dilated MPDPathology: PDAC, stage IIB
#084M72CAPS5PCPCCyst136Cyst with 12-mm solid component in headPathology: PDAC arising in an IPMN, stage IA, IPMN, PanIN
#085M73CAPS5PCPCMass149Mass in head, 10-mm dilated MPDPathology: PDAC, stage IIB, PanIN-2
#086M65CAPS5PCPCMass127Mass in body, 8-mm dilated MPDPathology: PDAC, ypStage IIB
#088F77CAPS5PCPCMass129Mass in head, 6-mm dilated MPDPathology: PDAC, locally advanced, diagnosed by FNA
#094M53CAPS5PCPCMass130Mass in body, 5-mm dilated MPDPathology: PDAC, locally advanced, diagnosed by FNA
#097M51CAPS5PCPCMass124Mass in head, 6-mm dilated MPDPathology: PDAC, ypStage IIB
#101M85CAPS4PCPCMass, cyst235Mass in tail, 4-mm cyst in body, 4-mm dilated MPDPathology: colloid carcinoma arising in an IPMN, stage IA, IPMN HGD
#102M68CAPS4PCPCMass130Mass in head, 7-mm dilated MPDPathology: PDAC, stage IIB
#103M61CAPS4PCPCCyst131Cyst with solid compornent in body, 7-mm dilated MPDPathology: PDAC arising in an IPMN, stage IB, IPMN HGD
#106F62CAPS4PCPCMass125Mass in tail, 5-mm dilated MPDPathology: PDAC, stage IIB
  • Abbreviations: CBD, common bile duct; CT, computed tomography; ERCP, endoscopic retrograde cholangiopancreatography; F, female; FNA, fine-needle aspiration; HG, high grade; HGD, high-grade dysplasia; IGD, intermediate-grade dysplasia; LG, low grade; LGD, low-grade dysplasia; M, male; MPD, main pancreatic duct; na, not applicable; PC, pancreatic cancer; Precursor, surgical resection for precursors; ypStage, pathologic stage after neoadjuvant therapy.

  • aERCP.